kairospharma.com - Bathi operasional EBITDA KAPA
The development of therapeutic platforms at Kairos Pharma Ltd (KAPA) is leading to rising costs in the absence of operating leverage. The company's EBITDA demonstrates profit volatility, where 0.00 captures the current value of the indicator. Stability is provided by California centers and CDMO outsourcing, while success depends on FDA approval and the funding of clinical trials to combat cancer resistance.
Kairos Pharma (KAPA) - rincian metrik lan laporan keuangan
- kuotasi saiki lan rata-rata prakiraan nilai:
- rincian nilai pasar emiten:
- indikator nilai buku ekuitas:
- data tingkat utang lan likuiditas finansial:
Total Utang marang Modal Kairos Pharma Ltd|KAPA - Utang jangka dawa marang modal|Utang jangka cendhak marang modal Kairos Pharma Limited|KAPA - Gunggung utang perusahaan|Utang-utang marang aset resik Kairos Pharma|KAPA - Utang jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Kairos Pharma|Likuiditas darurat kairospharma.com
- statistik bathi lan rasio pasar:
KAPA - Bathi resik perusahaan|Prakiraan bathi perusahaan Kairos Pharma Ltd|KAPA - Koefisien rega marang bathi|Pangali mangsa ngarep rega marang bathi Kairos Pharma Limited|KAPA - Rasio rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi operasional sadurunge panyusutan Kairos Pharma|KAPA - Bathi operasional EBITDA|Bathi saben saham sajroning taun lumaku Kairos Pharma|KAPA - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan kairospharma.com|KAPA - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep Kairos Pharma Ltd
- indikator pendapatan dodolan lan penghasilan bisnis:
Ringkesan analitik perusahaan:KAPA Kairos Pharma Ltd
Investors in Kairos Pharma Ltd (KAPA) must account for binary outcome risks due to the company's narrow specialization in combating cancer therapy resistance. This metric measures cash flow from core operations before depreciation, reflecting the business's actual ability to act as a cash generator, which, on the EBITDA chart, allows for the identification of abnormal liquidity spikes and prevents overpaying for the asset.
Pesaing Kairos Pharma Ltd (KAPA)
ONC - Bathi operasional sadurunge ngurangi amortisasi|HALO: Bathi operasional sadurunge ngurangi amortisasi|RVMD - Bathi operasional EBITDA|Ascentage Pharma (AAPG) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|CG Oncology Inc - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|URGN (UroGen) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Bicara Corp BCAX|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Personalis, Inc. (PSNL)|Bathi operasional EBITDA erasca.com (ERAS)|Bathi operasional EBITDA DCTH (Delcath Systems)|Bathi operasional EBITDA Y-mAbs Therapeutics Inc YMAB|Aura Bio - Bathi operasional EBITDA|Pendapatan operasional sadurunge ngurangi amortisasi Candel Therapeutics CADL|Accuray Incorporated (ARAY) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|SELLAS Life Sciences Group - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Actuate Therapeutics|Bathi sadurunge bunga, pajak, lan amortisasi Citius Oncology Inc. CTOR|Bathi sadurunge mbayar bunga, pajak, lan amortisasi TuHURA Biosciences, Inc. (HURA)|Pendapatan operasional sadurunge ngurangi amortisasi Protara Tx|Fate Therapeutics, Inc. - Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi WHWK|TCRX - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi CSBR|XBIT: Bathi operasional EBITDA|CEL-SCI - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|OSTX (OS Therapies Incorporated) - Bathi operasional EBITDA|Bathi operasional EBITDA radiopharmtheranostics.com|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Artiva Biotherapeutics, Inc. (ARTV)|ANL (adlainortye.com) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Veru Pharma VERU|TPST - Bathi operasional sadurunge ngurangi amortisasi|Xilio - Bathi operasional EBITDA|RENB - Bathi operasional EBITDA|MURA (muraloncology.com) - Bathi operasional sadurunge ngurangi amortisasi|OnKure Therapeutics - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi CytoMed Therapeutics Ltd|Bathi sadurunge mbayar bunga, pajak, lan amortisasi CRIS|Bathi operasional sadurunge ngurangi amortisasi APLM (Apollomics, Inc.)|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi THAR|Bathi operasional EBITDA ADVB (Advanced Biomed)|GNPX: Bathi operasional sadurunge amortisasi|CLDI - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|SBFM - Bathi operasional EBITDA|XBIO: Bathi operasional EBITDA|salariuspharma.com (SLRX) - Bathi operasional EBITDA|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Purple Biotech Ltd.|AON - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Bathi operasional EBITDA BGNE|Bathi operasional EBITDA Checkpoint Therapeutics Inc (CKPT)|Bathi operasional EBITDA ELEV (Elevation Oncology)|ICAD - Bathi operasional sadurunge ngurangi amortisasi|Ikena - Bathi operasional EBITDA|NTBL - Bathi operasional EBITDA|viracta.com (VIRX) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi operasional sadurunge amortisasi MOR|NAYA (NAYA Biosciences) - Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi ascentage.com (AAPGV)
